Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 1051 to 1100 of 2003

TitleReference numberPublishedLast updated
Preventing suicide in community and custodial settingsNG105
Leadless cardiac pacemaker implantation for bradyarrhythmiasIPG626
Superior rectal artery embolisation for haemorrhoidsIPG627
Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumoursTA539
Sutureless aortic valve replacement for aortic stenosisIPG624
Flu vaccination: increasing uptakeNG103
Dinutuximab beta for treating neuroblastomaTA538
Transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasiaIPG625
Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDsTA537
Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodineTA535
Alectinib for untreated ALK-positive advanced non-small-cell lung cancerTA536
Community pharmacies: promoting health and wellbeingNG102
Dupilumab for treating moderate to severe atopic dermatitisTA534
Low-intensity pulsed ultrasound to promote healing of fresh fractures at low risk of non-healingIPG621
Low-intensity pulsed ultrasound to promote healing of fresh fractures at high risk of non-healingIPG622
Low-intensity pulsed ultrasound to promote healing of delayed-union and non-union fracturesIPG623
Superior capsular augmentation for massive rotator cuff tearsIPG619
Transaxial interbody lumbosacral fusion for severe chronic low back painIPG620
Ocrelizumab for treating relapsing–remitting multiple sclerosisTA533
Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancerTA531
Biomarker tests to help diagnose preterm labour in women with intact membranesDG33
Nivolumab for treating locally advanced unresectable or metastatic urothelial cancer after platinum-containing chemotherapyTA530
Beta interferons and glatiramer acetate for treating multiple sclerosisTA527
Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremorIPG617
Laparoscopic ventral mesh rectopexy for internal rectal prolapseIPG618
Dementia: assessment, management and support for people living with dementia and their carersNG97
Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's diseaseTA217
Intranasal phototherapy for allergic rhinitisIPG616
Brentuximab vedotin for treating CD30-positive Hodgkin lymphomaTA524
Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapyTA525
Arsenic trioxide for treating acute promyelocytic leukaemiaTA526
Guselkumab for treating moderate to severe plaque psoriasisTA521
Midostaurin for untreated acute myeloid leukaemiaTA523
Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and overNG36
Low-level laser therapy for preventing or treating oral mucositis caused by radiotherapy or chemotherapyIPG615
Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapyTA520
Percutaneous balloon valvuloplasty for fetal critical aortic stenosisIPG613
Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan IDG32
Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasiaIPG611
Microinvasive subconjunctival insertion of a trans-scleral gelatin stent for primary open-angle glaucomaIPG612
Robot-assisted kidney transplantIPG609
Nerve transfer to partially restore upper limb function in tetraplegiaIPG610
Tocilizumab for treating giant cell arteritisTA518
Care and support of people growing older with learning disabilitiesNG96
Learning disabilities and behaviour that challenges: service design and deliveryNG93
Emergency and acute medical care in over 16s: service delivery and organisationNG94
Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimenTA515
Cabozantinib for treating medullary thyroid cancerTA516
Physical activity and the environmentNG90
Brodalumab for treating moderate to severe plaque psoriasisTA511

Results per page

  1. 10
  2. 25
  3. 50
  4. All